Table 2.
One-year and five-year relative survival 1 by Indigenous status and cancer site/type, Australia, 2001-2005
| |
Indigenous |
Non-indigenous
2
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| |
Cases |
One-year |
Five-year |
Cases |
One-year |
Five-year |
||||
| Cancer site/type | n | % | (95% CI) | % | (95% CI) | n | % | (95% CI) | % | (95% CI) |
| Head and neck (C1-14, C30-32) |
236 |
60.3 |
(53.6-66.4) |
32.4 |
(25.6-39.5) |
11 893 |
86.1 |
(85.5-86.8) |
65.9 |
(64.9-66.9) |
| Stomach (C16) |
73 |
39.8 |
(28.3-51.1) |
16.9 |
(8.0-29.0) |
9 349 |
56.1 |
(55.1-57.1) |
30.7 |
(29.6-31.7) |
| Colorectal (C18-20) |
306 |
80.1 |
(74.8-84.6) |
58.5 |
(50.9-65.7) |
62 021 |
85.6 |
(85.3-85.9) |
66.3 |
(65.9-66.8) |
| Anus (C21) |
22 |
73.8 |
(49.9-88.0) |
49.1 |
(20.9-73.8) |
1 304 |
91.7 |
(89.9-93.1) |
70.4 |
(67.3-73.4) |
| Liver (C22) |
83 |
24.8 |
(16.0-34.6) |
11.2 |
(5.1-20.0) |
4 500 |
43.4 |
(41.9-44.9) |
19.9 |
(18.5-21.2) |
| Pancreas (C25) |
91 |
26.3 |
(17.6-35.9) |
11.2 |
(5.4-19.5) |
9 667 |
27.6 |
(26.7-28.5) |
7.6 |
(7.0-8.3) |
| Lung (C33-34) |
500 |
29.4 |
(25.4-33.5) |
9.1 |
(6.3-12.5) |
42 139 |
43.4 |
(42.9-43.9) |
16.7 |
(16.3-17.2) |
| Melanoma (C43) |
59 |
95.6 |
(84.4-100.7) |
73.8 |
(55.5-88.5) |
48 592 |
97.9 |
(97.7-98.1) |
92.4 |
(91.9-92.8) |
| Breast (C50) |
420 |
94.1 |
(91.0-96.4) |
80.1 |
(74.3-85.2) |
59 640 |
97.9 |
(97.7-98.0) |
89.5 |
(89.1-89.8) |
| Cervix (C53) |
109 |
79.8 |
(70.8-86.5) |
57.6 |
(46.6-67.4) |
3 475 |
90.8 |
(89.7-91.7) |
78.3 |
(76.7-79.8) |
| Uterus (C54) |
96 |
85.2 |
(75.9-91.4) |
78.7 |
(66.7-88.2) |
7 969 |
94.0 |
(93.5-94.6) |
84.6 |
(83.6-85.7) |
| Ovary (C56) |
53 |
77.1 |
(62.9-86.8) |
50.1 |
(33.6-65.1) |
5 777 |
83.5 |
(82.5-84.5) |
53.1 |
(51.6-54.6) |
| Prostate (C61) |
181 |
90.4 |
(84.0-94.9) |
83.6 |
(72.5-93.2) |
68 475 |
97.3 |
(97.1-97.4) |
91.0 |
(90.6-91.4) |
| Testis (C62) |
25 |
100.5 |
(100.5-100.5) |
94.5 |
(73.6-100.5) |
3 209 |
98.8 |
(98.3-99.2) |
96.9 |
(96.0-97.6) |
| Kidney (C64) |
69 |
77.5 |
(65.2-86.3) |
68.1 |
(53.0-80.7) |
10 522 |
84.9 |
(84.2-85.6) |
73.2 |
(72.1-74.2) |
| Bladder (C67) |
53 |
61.5 |
(46.4-74.0) |
54.7 |
(36.1-72.6) |
11 270 |
85.2 |
(84.5-85.9) |
68.1 |
(66.9-69.2) |
| Brain (C71) |
48 |
58.9 |
(43.6-71.4) |
42.2 |
(26.9-56.9) |
6 800 |
64.3 |
(63.2-65.5) |
40.4 |
(39.2-41.7) |
| Thyroid (C73) |
74 |
93.0 |
(83.9-97.5) |
85.0 |
(69.3-94.5) |
6 809 |
97.0 |
(96.5-97.4) |
96.0 |
(95.3-96.6) |
| Hodgkin lymphoma (C81) |
26 |
96.8 |
(76.2-100.1) |
100.6 |
(79.2-104.0) |
2 290 |
96.0 |
(95.1-96.8) |
90.3 |
(88.8-91.7) |
| NHL (C82-85, C96) |
101 |
67.4 |
(56.9-76.1) |
52.0 |
(37.3-65.8) |
18 392 |
85.5 |
(85.0-86.0) |
73.7 |
(72.9-74.5) |
| Leukemia (C91-95) |
108 |
64.6 |
(54.5-73.1) |
53.7 |
(42.7-63.9) |
12 864 |
80.3 |
(79.5-81.0) |
63.9 |
(62.9-64.9) |
| Unknown primary (C76-80) |
196 |
29.2 |
(22.8-35.8) |
14.9 |
(9.9-21.1) |
14 997 |
35.6 |
(34.9-36.4) |
21.3 |
(20.6-22.1) |
| Other |
363 |
61.1 |
(55.7-66.1) |
40.3 |
(34.4-46.2) |
42 463 |
78.5 |
(78.1-78.9) |
57.2 |
(56.7-57.8) |
| All cancers (C00-96, D45-47) | 3 292 | 63.8 | (62.1-65.5) | 46.7 | (44.6-48.7) | 464 417 | 83.4 | (83.3-83.5) | 70.0 | (69.8-70.2) |
1Relative survival rate.
2Age-adjusted to age distribution of Indigenous cases for each cancer site.